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Abstract 
Objectives: The aim of this study was to identify themes that determine health-related 
quality of life (HRQoL) in patients with carotid artery stenosis and identify the patient-
reported outcome measures that best cover the identified themes.  
Methods: A systematic review of the main six databases from inception to September 2018 
was undertaken to identify primary qualitative studies reporting on the HRQoL of patients 
with carotid artery stenosis.  Quality of studies was assessed using the CASP criteria. 
Findings from the included studies were analysed using Framework Analysis methodology. 
The identified themes were mapped against the items/domains from the patient-reported 
outcome measures used previously in patients with carotid artery stenosis.  
Results: The systematic review identified four papers that fulfilled the inclusion criteria. The 
included papers reported the views of sixty-two patients with symptomatic carotid artery 
stenosis; twenty-four of the patients were awaiting assessment for intervention, twenty-six 
had carotid endarterectomy and twelve were turned down for intervention and received best 
medical therapy. The overall quality of the included studies was good based on CASP 
criteria.  Framework Analysis identified sixteen themes that were divided into six main 
domains: anxiety, impact on physical activity, effect on independence, impact on personal 
roles, psychological impact and symptoms. The best fit generic and disease specific PROMs 
were the Short-Form 36 (SF-36 ®) and the Carotid Stenosis Specific Outcome Measure 
(CSSOM) respectively. None of the PROMs covered all the themes identified in the 
qualitative systematic review.  
Conclusion: The findings from the review identified the important themes that affect patients 
with carotid stenosis disease.  The current generic and disease specific patient-reported 
outcome measures do not cover all themes that impact the HRQoL of patients suffering with 
this disease. The proposed themes can be used to develop a new disease specific PROMs 
to measure HRQoL.  
Key Points 
Carotid artery disease is the main cause of stroke; some patients with this disease 
can benefit from surgical intervention to reduce the risk of future stroke. 
 
 
Understanding and measuring quality of life in these patients can guide intervention 
decisions. 
 
This systematic review provides detailed overview of the impact of this disease on 
quality of life 
 
Introduction 
 
Carotid artery stenosis (CAS) is a major cause of stroke, accounting for about 20% of all cases 
(1-2). It is caused by either carotid artery lesion thrombosis or embolism this lesion.   
Patients with CAS can be asymptomatic or present with transient ischaemic attack (TIA) or 
stroke. Evidence shows that patients who present with disabling stroke with previous evidence 
of CAS can benefit from preventive procedures including carotid endarterectomy (CEA) and 
stenting (3-10); however, these procedures are not risk free and can be complicated with 
perioperative stroke.  The symptoms and the uncertainty of outcome can impact the daily living 
of patients with CAS. Therefore, several clinical studies that investigated the efficacy and 
safety of different preventative interventions used patient-reported outcome measures 
(PROMs) to investigate the impact of the disease and treatment on health-related quality of 
life (HRQoL). However, due to a lack of validated PROMs they either used generic PROMs 
(11-14) or developed and used questionnaires without validation (14).  
Patients presenting with symptomatic and asymptomatic CAS need support to choose the 
best treatment strategy to help reduce their risk of stroke and improve their HRQoL. Patients' 
experience of disease and impact of treatment is a major indicator of quality and it is only 
through better understanding of the impact of the disease on HRQoL that PROMs can be 
developed. It is argued that PROMs, when designed carefully (e.g. based on input from 
patients’ experiences), can measure the issues of most importance to patients and any 
changes to their HRQoL because of the disease or as consequence of the treatment they may 
have received (15). 
 
The aim of this study was to systematically review the qualitative evidence to identify the 
impact of CAS and treatment pathway on patients’ HRQoL. The identified themes were then 
mapped against the items and domains from the generic and disease specific PROMs we had 
previously identified (16,17). The mapping was done to find the PROMs that captured the most 
important issues to patients with CAS.  
Method 
 
The systematic review aimed to identify all primary qualitative research studies that 
investigated the impact of CAS on HRQoL. The inclusion criteria included any patients with 
CAS and any studies with undefined population were excluded. For further information 
regarding the inclusion and exclusion criteria refer to table 1.  
This systematic review was undertaken and reported in accordance with the general principles 
recommended in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) statement. In accordance with the study protocol (18), searches were conducted 
from inception up to April 2017 and further updated to September 2018, in the following 
bibliographic databases; CINAHL via EBSCO, Medline and Medline in Process via Ovid, 
Embase via Ovid, PsycINFO via Ovid, Social Science Citation Index/ Science Citation Index 
via Web of Science (Thomson Reuters) and Proquest dissertations and theses. No language 
or date constraints were applied.  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1:  Summary of the inclusion and exclusion criteria 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inclusion Exclusion 
Patients’ experience of living with carotid 
artery stenosis and its impact on their health-
related quality of life. 
Studies not in English 
Studies with participants under 16 
years of age 
A defined population of participants with a 
diagnosis of carotid artery stenosis (CAS) 
who need, have had or are undergoing 
surgical treatment. Participants undergoing 
treatment for stroke or transient ischaemic 
attack (TIA) secondary to a diagnosis of 
CAS. 
Patients with Stroke or TIA not 
related to CAD 
Studies that include semi-structured 
interviews, descriptions, focus groups either 
as stand-alone studies or embedded in a 
quantitative study. Must include both data 
collection and data analysis 
Quantitative studies with no 
primary qualitative data reported 
Published or unpublished; 
Full-text or structured abstract with all 
relevant information 
Full-text or structured abstract with 
incomplete or unclear evidence 
 The search strategy combined condition terms, terms for patient views and terms for 
qualitative studies (which augmented a qualitative study filter) (19). Further details of the 
search strategy are provided in Appendix 1 (supporting information).  
 
Study selection 
The search results were uploaded into Endnote X8™ (Thomson Reuters, Philadelphia, USA), 
two reviewers (AA, AH) independently screened the titles for inclusion and exclusion in 
accordance with the set criteria in the protocol. All titles were examined, and any citations that 
clearly did not meet the inclusion criteria (for example mixed population, quantitative PROMs 
data) were excluded. For included titles, abstracts were read and for the included abstracts, 
full-text articles were obtained.  
 
Quality assessment 
The Critical Appraisal Skills Program (CASP) qualitative checklist instrument was used to 
examine the methodological quality of the included studies (20). This was selected for its 
appropriateness as it is commonly used in qualitative reviews of evidence (21). Two of the 
authors (AA, AH) independently examined the quality of each study and any inconsistencies 
were resolved by discussion or involving a third author (GJ).   
 
 
Data extraction and analysis 
The data on authors, year of publication, country of study, number of participants, research 
aims, methods of recruitment, method of data collection, key results and analysis were 
extracted and tabulated for all the included studies by the first author.  The included papers 
were uploaded into the qualitative data analysis software NVIvo10 (QSR International, 
Doncaster, Victoria, Australia) and the primary and secondary text (patient quotes reported in 
the articles and themes), were analysed. The inductive process of framework analysis was 
used for the qualitative evidence synthesis. In another systematic review (17); the PROMs 
used for this condition were examined for their validity; their conceptual domains were used 
to give a basis for the qualitative data synthesis (22). The first stage of the framework analysis 
was reading all the included papers and identifying common themes from within and across 
the articles. The second stage involved establishing a thematic framework by creating a list of 
the main themes based on the domains of validated PROMs and common themes in the 
identified papers. In the third stage the thematic framework was applied to all the primary and 
secondary data. In the final stage themes were examined for their conceptual similarities and 
differences. The second author (AH) checked all the themes that were identified and 
differences in conceptualization were discussed and adjusted involving a third senior author 
(GJ). 
 
Triangulation of PROMs items with qualitative themes 
A triangulation of evidence was performed to examine how the items within generic and 
disease specific PROMs corresponded to themes from the qualitative review (23,24).  The 
items from generic and disease specific PROMs used in patients with CAS (17) were 
examined in detail. The items from these instruments were mapped against the themes 
identified, and two researchers (AA, AH) reviewed both the themes from the qualitative review 
and the items/ from each PROM to evaluate whether the concepts were the same 
(agreement), offered similar concepts (partial agreement) or were not present (silence). The 
aim was to identify whether any of the instruments covered the issues that are important to 
patients with carotid artery disease.  
Results 
 
The database searches identified 1,095 citations; after removing duplicates, 859 titles were 
assessed and subsequently fifteen full-text papers were reviewed in detail. Finally, only four 
papers fulfilled the inclusion criteria and were included in the qualitative evidence synthesis 
(Please see PRISMA chart (Figure 1)). The studies included in the qualitative synthesis are 
summarized in table 2.  
 
 
Table 2. Qualitative studies exploring living with carotid artery stenosis 
 
Author 
(Year) 
Country Research 
Design 
Method of 
Analysis 
Age 
(years) 
Sample Diagnosis 
/Treatment 
Study Aims and 
Objectives 
Gibson 
(2002) 
(25) 
UK Qualitative 
semi-
structured 
interviews 
Grounded 
Theory 
Age, 
mean 
70.9 
(50-79) 
 
6 
Participants 
 
 
Male (%): 
50 
Symptomatic 
carotid 
stenosis 
 
Medical 
management: 
1 
 
Post CEA: 5  
 
Explore ways in 
which patients 
comprehend and 
live with risk of 
CEA or medical 
management only 
for carotid 
stenosis. 
Halin et 
al. 
(2002) 
(26) 
Sweden Mixed 
methods 
including a 
qualitative 
component 
using 
semi-
structured 
interviews  
Thematic 
analysis 
Age, 
mean 
71 (56-
80) 
 
20 
Participants 
Male (%): 
60 
Symptomatic 
carotid 
stenosis 
Medical 
management, 
no 
intervention: 1 
Post CEA: 11 
Pre-CEA or 
Stent: 8 
Assess quality of 
life of patients with 
carotid artery 
stenosis 
Gibson 
& 
Watkins 
(2012) 
(27) 
UK In-depth 
interviews 
 
Grounded 
Theory 
Age, 
Mean 
71.6(50-
80) 
16 
Participants  
Male (%): 
65 
Symptomatic 
carotid 
stenosis 
 
Explore the lived 
experience of 
patients with TIA 
secondary of 
carotid stenosis 
Gibson 
& 
Watkins 
(2013) 
(28) 
UK In-depth     
semi-
structured 
interviews  
 
Thematic 
analysis 
Age, 
mean 
70.2 
(50-80) 
 
20 
Participants 
Male (%): 
65 
 
TIA/Recovered 
stroke 
Post CEA: 10 
 
Medical 
management: 
10 
 
To examine the 
use of formal and 
informal 
knowledge by 
patients in making 
decisions about 
(CEA) and 
medical treatment 
after TIA ⁄ 
recovered stroke 
caused by carotid 
stenosis  
 
Abbreviations: Carotid revascularisation Enarterectomy (CEA), Transient ischaemic attack (TIA) 
 
 
 
 
 
 
 
  
 
 Figure 1. PRISMA Diagram: CS Qualitative Systematic Review   
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Additional records identified 
through other sources  
(n = 4) 
Records after duplicates removed  
(n = 874) 
Records excluded  
(n = 859) 
Full-text articles assessed 
for eligibility  
(n = 15) 
Full-text articles excluded, 
with reasons  
(n = 5) 
 
Non-qualitative study  
(n = 4) 
Wrong population 
(n =2) 
 
 
Studies included in 
qualitative synthesis  
(n = 4) 
  
 
Three of the included studies were from the UK (25, 27-28) and one from Sweden (26). The 
studies were published between 2002 and 2013; the age of patients with carotid artery 
disease in the included studies ranged from 50-80 years, and the percentage of male 
participants was 50-65%. The included studies reported the views of sixty-two patients with 
twenty-four of the patients awaiting assessment for surgery, twenty-six had surgery and 
twelve were turned down for intervention and received best medical therapy.  
 
Quality assessment  
The quality of the included studies was assessed independently by two authors (AA, AH) 
using the CASP checklist (10) for qualitative studies, any disagreement on the final score 
was resolved through discussion and/or involving a third senior author (GJ).  The overall 
quality of the included studies was good, and all the studies scored “yes” for almost all the 
criteria set in the CASP checklist; Only one study scored ‘can’t tell’ on the rigour of the data 
analysis (25). For detail on the quality of the included studies see table 3. 
 
 
 
 
 
 
 
 
 
Table 3: CASP checklist final score for included studies 1 
Paper CASP Quality Appraisal 
 1. Was 
there a 
clear 
statemen
t of the 
aims? 
2. Is a 
qualitative 
methodology 
appropriate? 
3. Was the 
research 
design 
appropriate 
to address 
the aims of 
the 
project? 
4. Was the 
recruitment 
strategy 
appropriate 
to the aims 
of the 
research? 
5. Was 
the data 
collected 
in a way 
that 
addresses 
the 
research 
issue? 
6. Has the 
relationship 
between 
researcher 
and 
participants 
been 
adequately 
considered? 
 
7. Have 
ethical issues 
been taken 
into 
consideration? 
8. Was the 
data 
analysis 
sufficiently 
rigorous? 
9. Is 
there a 
clear 
statement 
of 
findings? 
10. How 
valuable 
is the 
research? 
Gibson 
2002 
(25) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
? 
 
 
 
 
Hallin 
et al.  
2002 
(26) 
          
Gibson 
& 
Watkin
s  
2012 
(26) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gibson 
& 
Watkin  
2013 
(28) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
Analysis 3 
The Framework Analysis of the primary and secondary data of the included papers identified 4 
sixteen themes. These were divided into five main domains comprising; anxiety, impact on 5 
personal roles, effect on independence, psychological impact and symptoms. Please see 6 
Table 4 for further details.  7 
 8 
 9 
 10 
Table 4: Themes identified from qualitative research studies of patients with carotid 11 
artery stenosis. 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
Themes (Domains in bold 
font) 
 
Gibson 
(2002) 
Halin et 
al. 
(2002) 
Gibson & 
Watkins 
(2012) 
Gibson & 
Watkins 
(2013) 
 
Anxiety     
Fear of stroke √ √ √ √ 
Fear of becoming a burden  √ √ √ √ 
Fear of operation  √ √  √ 
Uncertainty about future √ √ √ √ 
Impact on personal roles & 
activities  √ √ √ √ 
Effect on independence  √ √ √ √ 
Psychological impact      
Happiness  √  √ √ 
Health perception √    
Symptoms      
Weakness   √  
Numbness or loss of sensation   √  
Loss of ability to speak    √  
Loss of vision    √  
Cognitive function   √  
Duration of symptoms   √  
Neck stiffness  √  √  
 22 
Anxiety 23 
 24 
The anxiety domain had several themes including fear of stroke, fear of becoming a burden, 25 
worry and uncertainty and fear from consequences of the operation. These four themes were 26 
grouped together because of overlapping. The impact of anxiety on daily living of patients 27 
suffering with CAS featured in all four studies. Patients experiencing symptoms of transient 28 
ischaemic attack (TIA) secondary to CAS expressed concern about fear of stroke, patients 29 
said: 30 
“I'm afraid of having a stroke and then becoming paralysed” (Pre-operative patient, 31 
age not reported) (26) 32 
“I’d be worrying a lot, yes, wondering when or where or how it (stroke) was going to 33 
happen…it would be in the back of my mind…which takes some of the pleasure out of life.” 34 
(Patient experienced TIA –before CEA) (27) 35 
“Well, I wouldn’t like to be here and have one (stroke) on my own.” (Patient 36 
experienced TIA –before CEA) (25) 37 
 38 
Two of the major causes for worry from having symptomatic CAS that can cause stroke were 39 
uncertainty and fear of becoming a burden. Participants in the included studies reported 40 
feeling that their life was put on hold and many were worried that a disabling stroke may make 41 
them a burden on others including their family members.  42 
 “It’s the unknown isn’t it, that’s what makes you fearful, you don’t know what’s going 43 
to happen.” (patient after the CEA reflecting on experiences prior to the surgery) (25) 44 
“I'm afraid of becoming dependent on care” (Pre-operative patient) (26) 45 
 46 
The uncertainty about the future and fear of sudden stroke was affecting patients treated with 47 
best medical therapy when compared to patients treated with preventive procedures such as 48 
CEA or stenting (27).  Another source of anxiety was the worry from complications of surgery 49 
including death or stroke. Many patients’ perceptions about the risk of stroke from the 50 
preventive procedures were disproportionate (25), some patients thought that their risk of 51 
stroke from the surgery was 50% and this higher than the 2% reported by clinical studies (3,4). 52 
Furthermore, many patients had an inaccurate recall of the risks of treatment options offered 53 
to them (25). 54 
“if somebody tells you there’s a 50% chance of having a stroke (without surgery) 55 
that’s in your mind all the time” (patient after the CEA reflecting on experiences prior to the 56 
surgery) (25) 57 
 58 
“You’re damned if you do and damned if you don’t, I mean I’d have a stroke if I didn’t 59 
have it, and I might have the stroke under the operation.” (Patient experienced TIA –before 60 
CEA) (25) 61 
 62 
Patients with successful revascularisation reported improved psychological wellbeing and 63 
felt that they could move on with their lives compared to the time prior to their procedure 64 
when they felt that their daily livings were overshadowed by the worry associated with the 65 
CAS diagnosis and possible stroke (25).  66 
I’m a happier person, physically and emotionally.” (patient after the CEA reflecting on 67 
experiences prior to the surgery) (25) 68 
Impact on Personal Roles & Activities  69 
 70 
Some participants in the included studies described the onset of symptomatic CAS to have 71 
put a hold on their life and without the preventative surgery, they would have not been able 72 
to carry on with their personal roles and daily activities (25). Some patients took many 73 
measures in their daily living to avoid activities that they perceived may increase their risk of 74 
further TIA or major stroke. For instance, some patients made changes to their diet (26). 75 
One patient said: 76 
 77 
“I’d have been worried about having a stroke, it curtailed my activities” (Post-78 
operative patient) (26) 79 
 80 
The anxiety associated with further TIA or strokes as well as residual symptoms of strokes 81 
had an impact on the physical functioning of the patients (25).Patients also suggested that 82 
the symptomatic CAS causing TIA dramatically changed their perception about their physical 83 
health, Furthermore, attitude of family and friend reinforced this view of diminished physical 84 
function (27). 85 
 “I’ve always kept my health…this has absolutely shattered me.” (Patient experienced 86 
TIA) (27) 87 
“you’re not as ﬁt as you thought you were, everybody’s always telling me to be 88 
careful, and have a rest…people around me have sort of convinced me that I’m a bit 89 
fragile…” (Patient experienced TIA) (27). 90 
Effect on Independence    91 
 92 
All the included studies reported that patients suffering with CAS felt that their social life and 93 
independence were compromised because of the disease and potential consequences. 94 
Patients expressed concerns about the impact of the disease and possible consequences of 95 
on their independence.  96 
“I'm afraid of becoming paralysed and dependent on care” (patient reporting after 97 
surgery) (25) 98 
  99 
 “I’ m enjoying life and I want it to go on, without having a stroke” (patient reporting 100 
after surgery) (28) 101 
 102 
 103 
Psychological Impact  104 
 105 
Patients suffered with issues related to their health perception; the diagnosis had adverse 106 
consequences for many patients; with some reporting that they felt their daily life is being 107 
shattered with the new diagnosis (27).  108 
Some patients developed low mood when they understood the risks associated with their 109 
disease, however, on the other hand, patients who had the operation and did not experience 110 
any complications reported that they felt happier emotionally because of dealing with a 111 
potentially significant disease that made them felt unhappy (25, 27-28). One patient 112 
reported: 113 
 “I’m a happier person, physically and emotionally.” (patient reporting after 114 
surgery) (25) 115 
 116 
Symptoms  117 
 118 
The symptomatic outcomes that were reported by the patients could be divided broadly into 119 
two main groups: symptoms associated with TIA and post-intervention symptoms. Patients 120 
experiencing TIA reported classical symptoms including loss of sensation, weakness, 121 
temporary loss of ability to speak and loss of vision (27).  122 
 “I couldn’t pick anything up at all, I had great difﬁculty in using the knife and 123 
fork…and then suddenly it came back.”(Patient reporting TIA symptoms) (27) 124 
“I just thought a ﬁlm had come over my eye.” (Patient reporting TIA symptoms) (27) 125 
 126 
Patients described symptoms of neck pain and discomfort at the site of operation to treat 127 
CAS following CEA (25).  128 
 “….did feel better, apart from residual minor discomfort from surgical incision 129 
pain and neck stiffness.” (patient reporting after surgery) (25) 130 
 131 
Lastly, some patients described loss of cognitive function that was noticeable by their family 132 
and caused concern for the patient (25). 133 
 “I have difficulties taking part in advanced discussions''(patient with carotid artery 134 
stenosis) (25) 135 
Triangulation 136 
The identified themes were compared to items from PROMs that were identified in a recent 137 
study (17). These PROMs include the carotid artery disease quality of life questionnaire 138 
developed by the Carotid revascularisation Enarterectomy vs. Stenting Trial group (CREST 139 
Randomised controlled trial), Carotid Stenosis Specific Outcome Measure developed by 140 
Ivanova et al (28), Dizziness Handicap Inventory (DHI), Hospital Anxiety and Depression 141 
Scale (HADS), EuroQoL-5D (EQ-5D), and the Short-Form 36 (SF-36 ®).  Two reviewers (AA, 142 
AH) examined the overlap between the themes in the qualitative review and items in the 143 
PROMs. When there was complete overlap between the theme and an item in an instrument 144 
an agreement score (+) was awarded; however, when the theme is covered in a  145 
general question a partial agreement score was awarded (+/-).  146 
 147 
 148 
Table 5: Themes identified from the qualitative review mapped against items of 149 
validated PROMs 150 
 151 
 152 
 153 
Themes CREST 
trial 
PROMs 
CSSOM DHI HADS EQ-5D SF-36 
Anxiety  - + +/- + + + 
Fear of stroke - - - - - - 
Fear of becoming a burden  - + - - - - 
Fear of operation  - - - - - - 
Uncertainty about future - - - - - - 
Impact on personal roles & 
activities - + + +/- - - 
Effect on Independence  - - +/- - - - 
Psychological impact  - + + + +/- + 
Happiness  - + + + - + 
Health Perception  - - - - - - 
Symptoms +/- + + - - - 
Weakness - + +/- - - - 
Numbness or loss of sensation - + - - - - 
Loss of ability to speak  - - - - - - 
Loss of vision  - + - - - - 
Cognitive function  - + - - - - 
Duration of symptoms - - - - - - 
Neck Stiffness  + + - - - - 
Abbreviations: Carotid revascularisation Enarterectomy vs. Stenting Trial (CREST Randomised controlled trial), 
Dizziness Handicap Inventory (DHI), Hospital Anxiety and Depression Scale (HADS), EuroQoL-5D (EQ-5D), and Medical 
outcomes study 36-item short form (SF-36 ®), Carotid Stenosis Specific Outcome Measure (CSSOM). 
Scores: −, silence; −/+, partial agreement; +, agreement. 
 
None of the identified PROMs covered important HRQoL themes such as fear of stroke or fear 154 
from the operation as well as uncertainty about future caused by the diagnosis of the disease. 155 
Many of the symptoms described in the qualitative evidence synthesis of this study were not 156 
included in the PROMs used previously. The generic PROM that captured most of the 157 
important issues for patients with CAS was the SF-36 ® and the disease specific PROM was 158 
the PROMs for carotid artery disease developed by Ivanova et al (28). However, both PROMs 159 
did not cover all the themes identified in this review. For further details on the results of 160 
triangulation see table 5. 161 
 162 
Discussion 163 
 164 
We identified six domains that impacted upon the HRQoL of patients with CAS throughout 165 
their care pathway. These include anxiety, impact of the disease on personal roles/ activities, 166 
impact on physical functioning, impact on social functioning, psychological impact, and 167 
symptoms associated with it.  168 
The HRQoL of patients with CAS undergoing either revascularisation or best medical 169 
therapy have only been measured using generic PROMs, anxiety specific PROMs and 170 
questionnaires developed by clinicians with no validation (RCT) (5-11).  A single RCT 171 
attempted to develop a disease specific PROM for patients with CAS (11) however, the 172 
instrument was made of the six items suggested by clinicians and, more importantly, patients 173 
were not consulted.  Furthermore, there was no further validation for this PROM.  174 
Clinical outcomes such as 30-days mortality, stroke-free survival, and re-stenosis have been 175 
used to compare the efficacy of surgical, radiological and medical therapies for patients with 176 
CAS. These are important outcomes, however, HRQoL, when measured using a validated 177 
PROM can provide comprehensive data about the impact of different therapies. The themes 178 
from this review can be used to develop a more tailored PROM that can be used in routine 179 
clinical practice both to inform discussion between patients and clinicians, as well as, a 180 
quality measure of the carotid revascularisation service.  181 
 182 
One of the strengths of this study is that the qualitative review included patients at different 183 
stages of their care pathway including sixty-two patients with symptomatic carotid artery 184 
stenosis; twenty-four of the patients waiting for to meet a clinician to decide whether they are 185 
suitable for surgery or stenting, twenty-six patients had carotid endarterectomy with no 186 
complications and twelve patients turned down for surgical or interventional radiology 187 
procedures. This review used the evidence from an earlier systematic review (11) by the 188 
same group to evaluate the validity of PROMs used in patients with CAS.  This earlier 189 
systematic review was performed to examine the psychometric validation evidence for 190 
PROMs used in patients with CAS. In the triangulation section of this study the themes from 191 
the qualitative review were mapped against the items from the generic and disease specific 192 
CAS PROMs that were identified.  193 
 194 
The main limitation of this study is that it relies on the primary and secondary data of existing 195 
studies. The patients sampled in one of the studies only included patients with CAS waiting 196 
for operation (27); whereas, the other three studies included patients on best medical 197 
therapy for CAS as well as patients waiting for preventive surgery and patients following their 198 
operation.  Furthermore, the included studies beside investigating aspects of HRQOL also 199 
examined issues such as decision making about management that were not related to 200 
HRQoL. Additionally, few patients who were treated with best medical therapy or turned 201 
down for revascularisation were included in any of the studies. The included papers did not 202 
distinguish clearly between patients with resolved stroke symptoms and TIA. Some papers 203 
mentioned important themes such as denial of diagnosis and depression but failed to report 204 
any primary evidence to support these themes (27, 28). 205 
 206 
Amongst some clinical academic circles HRQoL has confusingly come to be known as 207 
anything which is not clinical (30).  However, this study demonstrates that patients with CAS 208 
experience distress related to diagnosis and the risks associated with the intervention. 209 
These have an adverse impact on their wellbeing and should be taken into consideration by 210 
the clinician. The review identified anxiety to be an important domain that impacts the 211 
HRQoL of patients with CAS and this is related to fear of stroke, uncertainty about future, 212 
fear of becoming a burden on others and fear of operation. Carotid artery disease also had 213 
an impact of on the patient independence, the personal functioning and beyond anxiety had 214 
a further psychological effect on patients. 215 
This systematic review of the qualitative evidence combine all the relevant data concerning 216 
the impact of CAS and its treatments on the patients. One of the strongest finding of this 217 
study is that none of the generic and disease specific PROMs covered all the important 218 
issues for CAS patients revealed by this qualitative systematic review.  219 
Conclusions 220 
 221 
The identified themes that impact the HRQoL of patients with CAS can be used to develop a 222 
disease-specific PROM. Our group designed this instrument and currently validating this 223 
PROM in an extensive survey of patients with CAS.  The aim is to perform a factor analysis 224 
as well as further psychometric studies to ensure the PROM's validity, reliability, and 225 
responsiveness.  226 
 227 
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